-
-
-
-
-
-
-
Insmed Reports First-Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Insmed (INSM): FDA Grants Priority Review to Insmed's Brensocatib for Treatment of Bronchiectasis with PDUFA Target Action Date Set for August 12, 2025
-
-
-
-
-
-
-
Insmed (INSM) Reports FDA Advisory Committee Meeting to Review ALIS as Treatment for NTM Lung Disease
-
-
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

